At a minimum, the region can absorb USD 2.6 billion in venture capital for bio startups over that period. If more companies are created and the step from preseed to seed improves, the figure can reach USD 5.5 billion.
The analysis compares the region’s roughly 400 bio startups with a global benchmark of equivalent startups. It covers graduation rates between rounds, time between rounds, median capital raised per round, Latin American trajectories against the global benchmark, and 10-year scenarios driven by company creation and early graduation.
This work is a preliminary analysis. We are now developing a more robust and comprehensive report. If you would like to explore a strategic partnership to strengthen this model and extend its reach, write to us.
